Attendees at the International Conference on Alzheimer's Disease in Chicago last week heard some exciting news: Scientists have been able to halt the progression of Alzheimer's during a recent clinical drug trial.

The use of blood-pressure drugs is linked to a lower incidence of Alzheimer's disease and a reduced likelihood of entering a nursing home, Boston University School of Medicine researchers found.

While no one knows for certain what causes us to age, prevailing wisdom suggests it's a buildup of stresses and the cumulative effects of disease. The surprising results of a recent study, however, say otherwise.

Nursing home residents are lashing out at each other verbally, physically and in other ways more often than previously believed, according to Cornell University-based researchers.

The risk of serious health problems, including death, are three times higher in seniors with dementia taking antipsychotic drugs, compared with those who don't, Canadian researchers say.

Anticholinergics - a group of drugs commonly prescribed to treat conditions such as Parkinson's disease, urinary incontinence and acid reflux - may cause a more rapid decline in cognitive function among the elderly than previously thought, according to investigators.

Study subjects who took ibuprofen for at least five years registered a 40% lower risk of developing Alzheimer's disease, according to new research. Some medicines in the same non-steroidal anti-inflammatory (NSAID) class cut the risk of Alzheimer's by 25%.

The majority of Parkinson's patients will develop some form of dementia as they age, which will affect their life expectancy, according to a research team from Norway.

Antipsychotic drugs are essentially useless when it comes to treating Alzheimer's disease, according to a newly released study from Britain.

Stephen McConnell, VP for advocacy and public policy, Alzheimer's Association